Site map
- Home
- Events & Presentations
- Press Releases
- More on AF
- AF and its Management
- AF Facts and Figures
- Dronedarone (Multaq®) A new advance in the management of atrial fibrillation
- Dronedarone Clinical Trial Programme and Clinical Evidence
- Sanofi-aventis commitment and dedication in atrial fibrillation
- Speakers biographies
- Stroke-Risk Reduction in AF
- The ATHENA Study - Addressing the cardiovascular complications of atrial fibrillation
- Record AF
- Scientific Papers
- Multimedia
- FAQ
- Glossary